Isolation and characterization of novel RECK tumor suppressor gene splice variants

Glioblastoma multiforme is the most common and lethal of the central nervous system glial-derived tumors. RECK suppresses tumor invasion by negatively regulating at least three members of the matrix metalloproteinase family: MMP-9, MMP-2, and MT1-MMP. A positive correlation has been observed between...

Full description

Bibliographic Details
Main Authors: Trombetta-Lima, Marina, Winnischofer, Sheila Maria Brochado, Demasi, Marcos Angelo Almeida, Filho, Renato Astorino, Carreira, Ana Claudia Oliveira, Wei, Beiyang, de Assis Ribas, Thais, Konig, Michelle Silberspitz, Bowman-Colin, Christian, Oba-Shinjo, Sueli Mieko, Marie, Suely Kazue Nagahashi, Stetler-Stevenson, William, Sogayar, Mari Cleide
Format: Online
Language:English
Published: Impact Journals LLC 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741753/
id pubmed-4741753
recordtype oai_dc
spelling pubmed-47417532016-03-11 Isolation and characterization of novel RECK tumor suppressor gene splice variants Trombetta-Lima, Marina Winnischofer, Sheila Maria Brochado Demasi, Marcos Angelo Almeida Filho, Renato Astorino Carreira, Ana Claudia Oliveira Wei, Beiyang de Assis Ribas, Thais Konig, Michelle Silberspitz Bowman-Colin, Christian Oba-Shinjo, Sueli Mieko Marie, Suely Kazue Nagahashi Stetler-Stevenson, William Sogayar, Mari Cleide Research Paper Glioblastoma multiforme is the most common and lethal of the central nervous system glial-derived tumors. RECK suppresses tumor invasion by negatively regulating at least three members of the matrix metalloproteinase family: MMP-9, MMP-2, and MT1-MMP. A positive correlation has been observed between the abundance of RECK expression in tumor samples and a more favorable prognosis for patients with several types of tumors. In the present study, novel alternatively spliced variants of the RECK gene: RECK-B and RECK-I were isolated by RT-PCR and sequenced. The expression levels and profiles of these alternative RECK transcripts, as well as canonical RECK were determined in tissue samples of malignant astrocytomas of different grades and in a normal tissue RNA panel by qRT-PCR. Our results show that higher canonical RECK expression, accompanied by a higher canonical to alternative transcript expression ratio, positively correlates with higher overall survival rate after chemotherapeutic treatment of GBM patients. U87MG and T98G cells over-expressing the RECK-B alternative variant display higher anchorage-independent clonal growth and do not display modulation of, respectively, MMP-2 and MMP-9 expression. Our findings suggest that RECK transcript variants might have opposite roles in GBM biology and the ratio of their expression levels may be informative for the prognostic outcome of GBM patients. Impact Journals LLC 2015-09-28 /pmc/articles/PMC4741753/ /pubmed/26431549 Text en Copyright: © 2015 Trombetta-Lima et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Trombetta-Lima, Marina
Winnischofer, Sheila Maria Brochado
Demasi, Marcos Angelo Almeida
Filho, Renato Astorino
Carreira, Ana Claudia Oliveira
Wei, Beiyang
de Assis Ribas, Thais
Konig, Michelle Silberspitz
Bowman-Colin, Christian
Oba-Shinjo, Sueli Mieko
Marie, Suely Kazue Nagahashi
Stetler-Stevenson, William
Sogayar, Mari Cleide
spellingShingle Trombetta-Lima, Marina
Winnischofer, Sheila Maria Brochado
Demasi, Marcos Angelo Almeida
Filho, Renato Astorino
Carreira, Ana Claudia Oliveira
Wei, Beiyang
de Assis Ribas, Thais
Konig, Michelle Silberspitz
Bowman-Colin, Christian
Oba-Shinjo, Sueli Mieko
Marie, Suely Kazue Nagahashi
Stetler-Stevenson, William
Sogayar, Mari Cleide
Isolation and characterization of novel RECK tumor suppressor gene splice variants
author_facet Trombetta-Lima, Marina
Winnischofer, Sheila Maria Brochado
Demasi, Marcos Angelo Almeida
Filho, Renato Astorino
Carreira, Ana Claudia Oliveira
Wei, Beiyang
de Assis Ribas, Thais
Konig, Michelle Silberspitz
Bowman-Colin, Christian
Oba-Shinjo, Sueli Mieko
Marie, Suely Kazue Nagahashi
Stetler-Stevenson, William
Sogayar, Mari Cleide
author_sort Trombetta-Lima, Marina
title Isolation and characterization of novel RECK tumor suppressor gene splice variants
title_short Isolation and characterization of novel RECK tumor suppressor gene splice variants
title_full Isolation and characterization of novel RECK tumor suppressor gene splice variants
title_fullStr Isolation and characterization of novel RECK tumor suppressor gene splice variants
title_full_unstemmed Isolation and characterization of novel RECK tumor suppressor gene splice variants
title_sort isolation and characterization of novel reck tumor suppressor gene splice variants
description Glioblastoma multiforme is the most common and lethal of the central nervous system glial-derived tumors. RECK suppresses tumor invasion by negatively regulating at least three members of the matrix metalloproteinase family: MMP-9, MMP-2, and MT1-MMP. A positive correlation has been observed between the abundance of RECK expression in tumor samples and a more favorable prognosis for patients with several types of tumors. In the present study, novel alternatively spliced variants of the RECK gene: RECK-B and RECK-I were isolated by RT-PCR and sequenced. The expression levels and profiles of these alternative RECK transcripts, as well as canonical RECK were determined in tissue samples of malignant astrocytomas of different grades and in a normal tissue RNA panel by qRT-PCR. Our results show that higher canonical RECK expression, accompanied by a higher canonical to alternative transcript expression ratio, positively correlates with higher overall survival rate after chemotherapeutic treatment of GBM patients. U87MG and T98G cells over-expressing the RECK-B alternative variant display higher anchorage-independent clonal growth and do not display modulation of, respectively, MMP-2 and MMP-9 expression. Our findings suggest that RECK transcript variants might have opposite roles in GBM biology and the ratio of their expression levels may be informative for the prognostic outcome of GBM patients.
publisher Impact Journals LLC
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741753/
_version_ 1613533903069380608